Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7472 p373
6 October 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


War of words breaks out over rural Scottish services

NHS boards should consult local residents to establish their views before approving pharmacy applications, BMA Scotland said this week. The association is concerned that dispensing doctors are under threat by the introduction of new pharmacies into small rural communities in Scotland.

Community Pharmacy Scotland hit back at the BMA, saying the suggestion that GP services were jeopardised was “ill-informed and flawed”.

The BMA said changes to the national pharmacy contract mean that community pharmacies are now more viable in smaller communities because of the additional services they can provide. “A consequence of this is that existing GP practices lose their dispensing rights and subsequently the loss of income limits their ability to deliver additional medical services to patients and could impact upon the provision of services and clinics locally,” it said.

Dispensing doctors, it added, believe that this represents a change to local service delivery and as such requires full public consultation under the arrangements set out in the NHS Reform (Scotland) Act 2004.

Andrew Buist, deputy chairman of the BMA’s Scottish General Practitioners Committee and lead on rural health issues, said: “Residents in local communities may welcome the establishment of a new local community pharmacy. However, if they were made aware of the impact that this could have on their ability to access a wider range of health care services from their local GP practice, then they may not be so enthusiastic.”

Alex MacKinnon, head of corporate affairs at CPS, responded: “What is being claimed ignores some basic facts, in particular that, under the new legislation, NHS boards are required to identify any shortfalls in their provision of pharmaceutical care and ensure that any such shortfalls are resolved. This is not simply some idle desire, but a legal obligation on boards to deliver the best possible pharmaceutical service and care to people, in line with Government policy.

“These claims also ignore the fact that dispensing doctors should only be operating in areas where it is not possible to have a pharmacy contract awarded. The best option is for pharmaceutical care to be provided by a pharmacist.”

Harry McQuillan

Harry McQuillan: Patients should have access to GP and pharmacy services

Harry McQuillan, CPS’s chief executive, added: “The terms of the new contract are nothing to do with viability, and everything to do with providing patients with access to health services. In addition, allowing pharmacists to treat minor ailments, for example, is mainly designed to ease pressure on GPs and other health care professionals.

“In our view it is quite wrong to somehow seek to persuade patients that they will be forced to choose between access to GP services or pharmacy services. NHS boards are properly charged in Scotland with deciding upon the provision of these services based on a full and professional appraisal of what is sustainable and appropriate. Where it is possible for patients to have access to both, then they should have that right.”

Susan Taylor, chairman of the Remote Practitioners Association of Scotland, said: “Rural dispensing GPs currently provide excellent services to their patients, but cannot access the new income streams available to community pharmacists. Destabilisation of these rural practices by the introduction of a new pharmacy could mean communities will lose access to a local GP service.”

Back to Top


©The Pharmaceutical Journal